These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27173977)

  • 21. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
    de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?
    Yung AR; Yuen HP; Berger G; Francey S; Hung TC; Nelson B; Phillips L; McGorry P
    Schizophr Bull; 2007 May; 33(3):673-81. PubMed ID: 17404389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.
    Fusar-Poli P; Palombini E; Davies C; Oliver D; Bonoldi I; Ramella-Cravaro V; McGuire P
    Schizophr Res; 2018 Feb; 192():385-390. PubMed ID: 28734908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood trauma and clinical outcome in patients at ultra-high risk of transition to psychosis.
    Kraan T; van Dam DS; Velthorst E; de Ruigh EL; Nieman DH; Durston S; Schothorst P; van der Gaag M; de Haan L
    Schizophr Res; 2015 Dec; 169(1-3):193-198. PubMed ID: 26585219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does specific psychopathology predict development of psychosis in ultra high-risk (UHR) patients?
    Thompson A; Nelson B; Bruxner A; O'Connor K; Mossaheb N; Simmons MB; Yung A
    Aust N Z J Psychiatry; 2013 Apr; 47(4):380-90. PubMed ID: 23399857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors contributing to the duration of untreated prodromal positive symptoms in individuals at ultra-high risk for psychosis.
    Chon MW; Lee TY; Kim SN; Huh MJ; Park HY; Lee CR; Shin NY; Kwon JS
    Schizophr Res; 2015 Mar; 162(1-3):64-6. PubMed ID: 25636994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.
    Takahashi T; Wood SJ; Yung AR; Phillips LJ; Soulsby B; McGorry PD; Tanino R; Zhou SY; Suzuki M; Velakoulis D; Pantelis C
    Schizophr Res; 2009 Jun; 111(1-3):94-102. PubMed ID: 19349150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining transition rates to psychosis: the role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndrome.
    Simon AE; Umbricht D; Lang UE; Borgwardt S
    Schizophr Res; 2014 Nov; 159(2-3):292-8. PubMed ID: 25263994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.
    Lavoie S; Schäfer MR; Whitford TJ; Benninger F; Feucht M; Klier CM; Yuen HP; Pantelis C; McGorry PD; Amminger GP
    Schizophr Res; 2012 Jul; 138(2-3):206-11. PubMed ID: 22520856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High remission rates from an initial ultra-high risk state for psychosis.
    Simon AE; Umbricht D
    Schizophr Res; 2010 Feb; 116(2-3):168-72. PubMed ID: 19854621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: A systematic review.
    Albert U; Tomassi S; Maina G; Tosato S
    Psychiatry Res; 2018 Dec; 270():1-12. PubMed ID: 30243126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up.
    Yung AR; Nelson B; Stanford C; Simmons MB; Cosgrave EM; Killackey E; Phillips LJ; Bechdolf A; Buckby J; McGorry PD
    Schizophr Res; 2008 Oct; 105(1-3):10-7. PubMed ID: 18765167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between social deprivation and the rate of identification of individuals at Ultra-High Risk for psychosis and transition to psychosis.
    Moore D; Eaton S; Polari A; McGorry P; Nelson B; O'Donoghue B
    Int J Soc Psychiatry; 2023 Mar; 69(2):294-303. PubMed ID: 35470718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study.
    Lunsford-Avery JR; LeBourgeois MK; Gupta T; Mittal VA
    Schizophr Res; 2015 May; 164(1-3):15-20. PubMed ID: 25818627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample.
    Burkhardt E; Berger M; Yolken RH; Lin A; Yuen HP; Wood SJ; Francey SM; Thompson A; McGorry PD; Nelson B; Yung AR; Amminger GP
    Schizophr Res; 2021 Jul; 233():24-30. PubMed ID: 34225023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Kelley ME; Wan CR; Broussard B; Crisafio A; Cristofaro S; Johnson S; Reed TA; Amar P; Kaslow NJ; Walker EF; Compton MT
    Schizophr Res; 2016 Mar; 171(1-3):62-7. PubMed ID: 26785806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intervention in individuals at ultra-high risk for psychosis: a review and future directions.
    McGorry PD; Nelson B; Amminger GP; Bechdolf A; Francey SM; Berger G; Riecher-Rössler A; Klosterkötter J; Ruhrmann S; Schultze-Lutter F; Nordentoft M; Hickie I; McGuire P; Berk M; Chen EY; Keshavan MS; Yung AR
    J Clin Psychiatry; 2009 Sep; 70(9):1206-12. PubMed ID: 19573499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.